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Objective: The aim of the present study was to examine the prevalence of insomnia
subtypes in relation to several demographic characteristics, as well as to investigate
the prevalence of possible anxiety and depression, alcohol consumption and use of
hypnotics within the different insomnia subtypes.
Methods: The present study was based on an extensive web-based survey made
publicly available in 2012. The data was downloaded in January 2019, after 113 887
people had responded to parts of, or the entire questionnaire. The 64 503 participants
who met the criteria for chronic insomnia disorder according to the Diagnostic and
Statistical Manual of Mental Disorders, fifth edition (DSM-5) comprised the study
population. The present study divided insomnia into seven subtypes based on type
of sleep difficulty reported; sleep onset insomnia (SOL-insomnia), sleep maintenance
insomnia (WASO-insomnia), early morning awakening insomnia (EMA-insomnia) and
combinations of these. Data were analyzed with chi-square tests and logistic regression
analyses adjusted for sex, age, level of education and marital status.
Results: More than 60% of the study population met the criteria of either SOL-
insomnia or a mixed insomnia subtype consisting of SOL-, WASO- and EMA-insomnia
(SOL + WASO + EMA-insomnia). The percentage distribution of insomnia subtypes
within the demographic characteristics showed that participants with female sex, high
age, low level of education and who were divorced, separated or a widow/widower had
a higher prevalence of SOL + WASO + EMA-insomnia compared to their respective
demographic counterparts. The prevalence of possible anxiety, possible depression
and use of hypnotics were higher among participants with SOL + WASO + EMA-
insomnia compared to the other insomnia subtypes. The combination of WASO-
and EMA-insomnia (WASO + EMA-insomnia) was associated with the most frequent
alcohol consumption.
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Conclusion: Our findings suggest that there are major differences between the
insomnia subtypes, both regarding demographics, but also in terms of how the
complaints may affect daily life. Participants with combinations of SOL, WASO and EMA
were more likely than participants with the other subtypes to have possible anxiety and
possible depression, high alcohol consumption and to use hypnotics.
Keywords: insomnia, insomnia subtypes, anxiety, depression, alcohol, hypnotics
INTRODUCTION
Insomnia is the most frequently occurring sleep disorder in
the adult population (Morin et al., 2006), with a prevalence
ranging from 5.8–20.0% when defined in accordance with formal
diagnostic criteria (Ohayon, 2002; Pallesen et al., 2014; Riemann
et al., 2017; Bjorvatn et al., 2018). Commonly identified risk
factors for insomnia are female sex, high age, low level of
education, and being separated, divorced or widowed (Ohayon,
2002; Taylor et al., 2005; Zhang and Wing, 2006; Atalay, 2011).
Alcohol consumption and use of hypnotics are also related
to insomnia (Ohayon, 2002; Atalay, 2011; Kim et al., 2017;
Brooks et al., 2018). According to the criteria found in the
fifth edition of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-5), insomnia disorder is defined as the subjective
experience of difficulty initiating sleep, maintaining sleep and/or
early morning awakening, occurring for at least three nights a
week for a duration of≥3 months. A further criterion is clinically
significant distress or impairment in important areas (e.g., social,
occupational, educational) of functioning (American Psychiatric
Association [APA], 2013).
DSM-5 discarded the distinction between primary and
secondary insomnia found in the previous version of the
diagnostic system (American Psychiatric Association [APA],
2013) and rather focused on a more bidirectional relationship
between insomnia and co-occurring medical and psychiatric
disorders (Jansson-Frojmark and Lindblom, 2008; Sivertsen
et al., 2012; Reynolds and O’Hara, 2013; Gupta et al., 2014).
By contrast, the previous edition, DSM-IV, focused more
on a causal relationship between coexisting disorders and
insomnia. However, the latter conceptualization could lead
to under-treatment of insomnia symptoms (National Institute
of Health [NIH], 2005; Manber et al., 2008; Gupta et al.,
2014). Previous studies have suggested that heterogeneity exists
within patients with insomnia disorder (Blanken et al., 2019).
Therefore, in addition to distinguishing between primary and
secondary insomnia or insomnia with or without comorbidity,
previous research has made repetitive attempts to further
divide patients with insomnia into different subtypes, based on
either sleep complaints or non-sleep characteristics (American
Psychiatric Association [APA], 2000; American Academy of
Sleep Medicine, 2005; Espie et al., 2012; Benjamins et al., 2017;
Blanken et al., 2019). To our knowledge, no previous subtyping
based on non-sleep characteristics has simplified the clinical
management of insomnia sufficiently to warrant amendments
in the clinical approach (Ferini-Strambi et al., 2019; Kitajima,
2019). Among others, this applies to a recent impressive study
by Blanken et al. (2019) who divided insomnia into subtypes
based on non-sleep characteristics such as life history, mood
perceptions, and personality. Other insomnia subtypes reported
in the literature have differentiated between insomnia with
normal and short sleep duration (Miller et al., 2018), insomnia
subtypes based on assumed etiology (e.g., psychophysiological,
paradoxical, inadequate sleep hygiene) (American Academy of
Sleep Medicine, 2005), data-driven/derived subtypes (Dekker
et al., 2015) and subtypes based on consistency (persistent,
remission, relapse) (Wu et al., 2014). The most commonly
used subdivision seems to concern when in the main sleep
period (sleep onset, maintenance, early morning awakening)
the symptoms occur (Hohagen et al., 1994; Yokoyama et al.,
2010). Overall, the most logical approach would be to subtype
according to specific sleep-related characteristics. Therefore, in
the present study we divided insomnia into subtypes based
on when the sleep difficulty was experienced during the
night (sleep onset insomnia, sleep maintenance insomnia and
early morning awakening insomnia) which as noted, represent
subtypes previously described in the literature (Taylor et al., 2005;
Pigeon, 2010; Yokoyama et al., 2010; Espie et al., 2012; Ikeda et al.,
2017). Even though there exist some research on demographic
characteristics associated with insomnia, there is a dearth of
research on the distribution of insomnia subtypes within these
characteristics.
As mentioned, the relationships between insomnia
and anxiety, and insomnia and depression are considered
bidirectional (Jansson-Frojmark and Lindblom, 2008; Baglioni
et al., 2010, 2011; Sivertsen et al., 2012; Alvaro et al., 2014; Dolsen
et al., 2014). To be able to predict which insomnia patients who
are more likely to suffer from psychiatric disorders, previous
studies have examined the prevalence of depression in specific
sleep-related subtypes (Rodin et al., 1988; Lustberg and Reynolds,
2000; Taylor et al., 2005; Yokoyama et al., 2010; Espie et al., 2012;
Ikeda et al., 2017). However, there are inconsistencies on which
subtype that most strongly has been associated with depression.
Historically, early morning awakening was considered a
characteristic of depression in the field of psychiatry (World
Health Organization [WHO], 1992) and several studies support
this notion (Rodin et al., 1988; Lustberg and Reynolds, 2000).
However, both Yokoyama et al. (2010), and Ikeda et al. (2017)
found that difficulty initiating sleep is more strongly associated
with depression than early morning awakening. Moreover,
other studies found combinations of different subtypes to be
more strongly associated with depression than early morning
awakening (Taylor et al., 2005; Espie et al., 2012). Even though
research suggests that insomnia overall is more strongly related
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to anxiety than depression (Taylor et al., 2005), it appears to exist
less research on the relationship between anxiety and insomnia
subtypes. Regarding hypnotics, a previous study by Espie
et al. (2012) found that patients reporting a mixed subtype of
insomnia were more likely to be taking prescribed sleeping pills
than other insomnia subtypes. Hohagen et al. (1994) reported
similar results. Alcohol consumption is a common self-treatment
strategy in patients with insomnia (Ohayon, 2002). Still, to
our knowledge, few previous studies have investigated the
distribution of alcohol consumption across subtypes of insomnia
(Ohayon, 2002; Ebrahim et al., 2013; Riemann et al., 2017).
Considering previous research, the present study aimed
to examine the distribution of demographic characteristics
such as sex, age, level of education and marital status across
subtypes of insomnia. We also aimed to investigate the
prevalence of alcohol consumption, use of hypnotics, possible
anxiety and possible depression within the different insomnia
subtypes. We hypothesized that these parameters would be
more prevalent when participants experienced a mixed insomnia
subtype consisting of all three nocturnal insomnia symptoms
(sleep onset insomnia, sleep maintenance insomnia and early
morning awakening) compared to experiencing one or two of
these separately.
MATERIALS AND METHODS
The present study was based on an extensive online interactive
questionnaire made publicly available on the webpage of the
Norwegian Competence Center for Sleep Disorders (www.sovno.
no) in February 2012, following information about this in
Norwegian newspapers and on a national television website. Staff
at the competence center and others have later recommended
people who suffer from sleep problems to complete the
online questionnaire. After completing all questions, participants
automatically receive feedback on the type of sleep disorder
they may suffer from, and advice on how to deal with the
problem. There are no specific inclusion or exclusion criteria.
The data used in the present study was downloaded in January
2019, after 113 887 people had responded to parts of, or the
entire questionnaire. A total of 3 309 participants reported
that they previously had completed the survey, consequently
their second responses were removed from the data. All
data concerned participants who subjectively stated problems
associated with sleeping.
Participants were asked about sex (male; female), age
(response alternatives ranging from 15 to more than 101 years),
level of education (primary school; secondary school; vocational
school; university), marital status (married; single; cohabitant;
divorced; separated; widow/widower) and circadian preference
(definitely morning type; more morning type than evening type;
neither morning type nor evening type; more evening type than
morning type; definitely evening type). Participants were asked
about alcohol consumption (yes; no). Those answering yes were
further asked about the frequency of alcohol consumption with
the following response alternatives «daily»; «3–5 days per week»;
«1–2 days per week»; and «rarely». The questionnaire did not
include a question about the amount of alcohol consumed. The
participants were also asked if they currently use hypnotics (yes;
no). We did not specify type of hypnotic, and whether they were
prescribed or over-the-counter medications. The participants
also reported the duration of their subjectively stated sleep
problem and were provided the following response alternatives:
“less than 6 months,” “6–12 months,” “1–2 years,” “2–3 years” etc.,
up to “more than 50 years.”
The Hospital Anxiety and Depression Scale (HADS) was
used to assess symptoms of anxiety and depression during
the last week. From a total of 14 statements, 7 of them
aim to detect anxiety, while the remaining 7 statements
aim to detect depression. Each statement has 4 response
alternatives reflecting increasing severity (0–3). HADS ≥ 8 in
the respective subscales was used to define possible anxiety and
possible depression (Bjelland et al., 2002). In the present study,
Cronbach’s alpha was 0.82 and 0.81 for HAD-anxiety and HAD-
depression, respectively.
Bergen Insomnia Scale (BIS) was used to evaluate insomnia
symptoms. BIS was initially developed according to the
diagnostic criteria for insomnia used in the 4th edition of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-
TR) (Pallesen et al., 2008). The presence of a specific insomnia
symptom the last month is scored along a scale indicating the
number of days per week it is experienced (0–7 days). BIS consists
of six items, of which the first three pertain to sleep onset, sleep
maintenance, and early morning awakening, respectively. The
participants are specifically asked if they used more than 30 min
to fall asleep after the light was switched off, if they were awake for
more than 30 min between periods of sleep, or if they awakened
more than 30 min earlier than they wished without being able
to fall asleep again. The last three items refer to not feeling
adequately rested, experiencing daytime impairment and being
dissatisfied with current sleep. The Cronbach’s alpha for the BIS
was 0.70 in the present study.
Chronic insomnia disorder was defined according to the
criteria from DSM-5 and the International Classification of Sleep
Disorders (ICSD-3) as scoring three days per week or more on
at least one of the first three items in addition to experiencing
daytime impairment and/or dissatisfaction with sleep three days
per week or more (American Psychiatric Association [APA],
2013; American Academy of Sleep Medicine, 2014). Participants
who met the criteria for chronic insomnia disorder were further
divided into subtypes. The main criterion to be diagnosed
with “Sleep onset latency insomnia” (SOL-insomnia) was to
have experienced sleep onset latency exceeding 30 min three
days per week or more the last month. Analogously, the main
criterion to be diagnosed with “Wake after sleep onset insomnia”
(WASO-insomnia) was wakefulness exceeding 30 min between
periods of sleep three days per week or more the last month,
and the main criterion to be diagnosed with “Early morning
awakening insomnia” (EMA-insomnia) was early morning
awakening exceeding 30 min three days per week or more the last
month. To be diagnosed with one of the three abovementioned
subtypes the participant could not show symptoms related to
the other two. Participants showing symptoms of more than
one of the first three subtypes were divided into the following:
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SOL+WASO-insomnia was diagnosed if participants met the
criteria of both SOL- and WASO-insomnia. SOL + EMA-
insomnia was diagnosed in participants meeting the criteria of
both SOL- and EMA-insomnia. EMA + WASO-insomnia was
diagnosed in participants meeting the criteria of both EMA-
and WASO-insomnia. SOL + WASO + EMA-insomnia was
diagnosed if participants met all three main criteria. Thus, a total
of seven specific subtypes of insomnia were defined.
Ethics
No personally identifiable information was stored in the collected
data file, thus the participants remained anonymous. The project
leader (BB) requested ethical approval by the Ethics Board (The
regional committee for Medical and Health Related Research
Ethics in Western Norway), who exempted the survey from
ethical review due to the anonymous nature of the study.
Statistics
IBM SPSS Statistics, version 25.0 was used for the data analyses.
Frequency analysis was conducted to provide a description of
the study population. Distribution of the insomnia subtypes
within the characteristics sex, age, education, marital status
and circadian preference was explored using Pearson’s chi
square tests. Furthermore, differences regarding use of alcohol,
hypnotics, possible anxiety (HAD-A≥ 8) and possible depression
(HAD-D≥ 8) according to each insomnia subtype were explored
using the same statistics.
Separate logistic regression analyses were conducted with
possible anxiety (HAD-A ≥ 8), possible depression (HAD-
D ≥ 8), use of hypnotics, and alcohol consumption as dependent
variables. The insomnia subtypes were used as predictors with
SOL-insomnia as the reference (OR = 1.00). Reported alcohol
consumption was dichotomized into high consumption (≥3 days
per week) and low consumption (<3 days per week). The first
analysis was unadjusted (crude), the second adjusted for age
and sex, whereas the third analysis adjusted for education and
marital status in addition to sex and age. Significance level was
set to P < 0.05.
RESULTS
A total of 78 577 participants answered questions about insomnia
disorder, of which 64 503 (82.1%) fulfilled the insomnia
criteria according to DSM-5, comprising the study population
(Figure 1). Among these, 87.1% reported a duration of insomnia
of six months or longer. Further characteristics of the study
population are summarized in Table 1. Mean age was 36.9 years
(SD = 14.6), with a preponderance of women (64.8%). A high
level of education predominated (49.0%). The majority of the
participants identified themselves as evening types, with 28.6%
answering “more evening type than morning type” and 26.8%
answering “definitely evening type.” The overall prevalence of
possible anxiety and possible depression was high among the
participants, with 63.3% and 39.2% having possible anxiety and
possible depression, respectively.
Table 2 presents the prevalence of the specific insomnia
subtypes among the participants who met the criteria for chronic
insomnia disorder. SOL + WASO + EMA-insomnia (32.7%)
followed by SOL-insomnia occurring alone (28.2%) were the
most common subtypes. All subtypes comprised more than
1900 participants. Table 2 also presents the distribution
of the insomnia subtypes within selected demographic
characteristics. As further detailed in the table, the prevalence
of SOL + WASO + EMA-insomnia compared to the other
FIGURE 1 | A total of 113 887 people responded to parts of, or the entire questionnaire. In all, 3 309 participants who reported that they previously had completed
the survey, got their second responses removed from the data. A total of 78 577 participants answered questions about insomnia disorder, of which 64 503 (82.1%)
fulfilled the insomnia criteria according to DSM-5. The prevalence of the specific insomnia subtypes among the participants who met the criteria for chronic insomnia
disorder is shown: SOL, sleep onset; WASO, wake after sleep onset; EMA, early morning awakening.
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TABLE 1 | Characteristics of the participants with chronic insomnia disorder






15–25 years 16417 (25.5)
26–35 years 15138 (23.5)
36–45 years 12940 (20.1)
46–55 years 11154 (17.3)
56–65 years 6328 (9.8)
Over 65 years 2523 (3.9)
Level of education: (missing 5)
Primary school 7955 (12.3)
Secondary school or vocational school 24918 (38.6)
University or college 31625 (49.0)
Marital status: (missing 5)
Single 24086 (37.3)
Married, cohabitant 35444 (54.9)
Divorced, separated, widow/widower 4968 (7.7)
Circadian rhythm (missing 1 913)
Definitely a morning type 5838 (9.3)
More morning type than evening type 9773 (15.6)
Neither morning nor evening type 12355 (19.7)
More evening type than morning type 17880 (28.6)
Definitely an evening type 16744 (26.8)
Alcohol consumption (missing 3 619)
No 20128 (33.1)
Rarely 18614 (30.6)
1–2 times per week 17286 (28.4)
3–5 times per week 4085 (6.7)
Daily 771 (1.3)
Use of hypnotics (missing 3 703)
Yes 10529 (17.3)
No 50271 (82.7)
Mental health (missing 1 439)
Possible anxiety (HAD-A ≥ 8)a 38949 (63.3)
Possible depression (HAD-D ≥ 8)b 24115 (39.2)
Duration of sleep problems (missing 0)
<6 months 8307 (12.9)
≥6 months 56196 (87.1)
aHAD-A = Hospital Anxiety and Depression Scale—Anxiety subscale. bHAD-
D = Hospital Anxiety and Depression Scale— Depression subscale.
subtypes was higher within females than within males. On the
contrary, the distribution of SOL-insomnia compared to the
other subtypes was lower within females than within males.
Age was positively associated with SOL + WASO + EMA-
insomnia, while inversely associated with the occurrence of
SOL-insomnia. In the age group 15–25 years, 47.1% were
diagnosed with SOL-insomnia, while 56.5% of participants
65 years or older were diagnosed with SOL + WASO + EMA-
insomnia. Participants within all three levels of education
showed a higher prevalence of SOL + WASO + EMA-
insomnia than they did of any other insomnia subtype.
Still, the highest proportion of SOL + WASO + EMA-
insomnia was found among participants with the lowest level
of education. Furthermore, single participants reported a
higher prevalence of SOL-insomnia than of other insomnia
subtypes, while participants who were married, cohabitant,
divorced, separated or a widow/widower showed a higher
prevalence of SOL + WASO + EMA-insomnia than of
other insomnia subtypes. Again, the highest percentage of
SOL + WASO + EMA-insomnia was found among the
participants who were divorced, separated or a widow/widower.
Being an evening type was clearly associated with SOL-insomnia.
Being a morning type was more commonly reported by
participants with SOL+WASO+ EMA-insomnia.
As presented in Table 3, WASO + EMA-insomnia was
associated with more frequent alcohol consumption (10.2%
reporting consumption of alcohol 3–5 times per week and
2.6% reporting a daily consumption), while SOL-insomnia
was associated with the least frequent consumption (4.9%
reporting consumption of alcohol 3–5 times per week and 0.6%
reporting a daily consumption). SOL+WASO+ EMA-insomnia
was associated with the highest use of hypnotics (26.8%)
in comparison to the other subtypes. All insomnia subtypes
were clearly associated with possible anxiety (50.8–68.1%) with
WASO-insomnia and SOL + EMA-insomnia representing the
lowest and highest association, respectively. Out of all insomnia
subtypes, SOL + WASO + EMA-insomnia was associated with
the highest prevalence of possible depression (46.0%), whereas
WASO-insomnia was associated with the lowest (32.5%).
The results from the logistic regressions with possible anxiety,
possible depression, alcohol consumption and use of hypnotics as
dependent variables are presented in Table 4.
Both crude and adjusted logistic regressions with possible
anxiety as the dependent variable showed a negative association
with WASO-insomnia compared to SOL-insomnia. Both EMA-
insomnia and WASO + EMA-insomnia were negatively
associated with possible anxiety compared to SOL-insomnia
in the crude analyses. While EMA-insomnia was no longer
significantly associated with possible anxiety compared to
SOL-insomnia in the adjusted analyses, WASO + EMA-
insomnia became positively associated. SOL+WASO-insomnia,
SOL + EMA-insomnia and SOL + WASO + EMA-insomnia
were all stronger predictors of possible anxiety than SOL-
insomnia, with SOL + WASO + EMA-insomnia being the
strongest predictor in the adjusted analyses. Furthermore, in
the crude analysis, SOL + WASO-insomnia, SOL + EMA-
insomnia and SOL+WASO+ EMA-insomnia were all stronger
predictors of possible depression than SOL-insomnia, with
SOL +WASO + EMA-insomnia being the strongest. Compared
to SOL-insomnia, all insomnia subtypes except WASO-insomnia
were positively associated with possible depression in the
adjusted analyses, with SOL + WASO + EMA-insomnia being
the strongest predictor (fully adjusted OR = 1.87).
Compared to SOL-insomnia, WASO-insomnia and EMA-
insomnia were inversely associated with use of hypnotics
in both the crude and adjusted analyses. WASO + EMA-
insomnia was positively associated with use of hypnotics
in the crude analysis, while negatively associated in both
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TABLE 2 | The percentage distribution of the specific insomnia subtypes within selected demographic parameters (n = 64 503).
SOL- WASO- EMA- SOL + SOL + WASO + SOL +WASO + Chi-square p-valueb
insomnia insomnia insomnia WASO-insomnia EMA-insomnia EMA-insomnia EMA-insomnia (df)a
% (n) 28.2 (18207) 3.0 (1944) 4.6 (2998) 12.1 (7834) 9.4 (6044) 9.9 (6387) 32.7 (21 065)
Sex
Male 30.4% 2.8% 5.6% 11.1% 8.7% 10.5% 30.9% 232.2 (6) <0.0005
Female 27.1% 3.2% 4.1% 12.7% 9.7% 9.6% 33.6%
Age
15–25 years 47.1% 1.4% 2.4% 14.1% 12.1% 1.8% 21.1% 11102.4 (30) <0.0005
26–35 years 37.2% 2.9% 4.2% 13.6% 10.5% 5.2% 26.4%
36–45 years 21.6% 3.9% 6.2% 11.8% 8.9% 12.4% 35.1%
46–55 years 11.7% 4.2% 6.4% 9.8% 7.2% 18.9% 41.8%
56–65 years 9.2% 3.6% 5.5% 10.0% 6.2% 18.7% 46.9%
>65 years 6.6% 3.2% 3.9% 8.5% 4.8% 16.4% 56.5%
Level of education
Primary school 29.1% 1.9% 3.5% 13.1% 10.7% 5.5% 36.2% 758.0 (12) <0.0005
Secondary school or
vocational school
28.3% 2.5% 4.2% 12.0% 10.0% 8.2% 34.7%
University or college 28.0% 3.7% 5.3% 12.1% 8.5% 12.4% 30.1%
Marital status
Married, cohabitant 22.3% 3.7% 5.7% 11.5% 8.3% 13.3% 35.2% 4008.4 (12) <0.0005
Single 39.4% 2.0% 3.1% 13.5% 11.0% 4.1% 26.9%
Divorced, separated,
widow/widower




5.8% 3.9% 10.1% 4.7% 7.8% 26.9% 40.9% 10314.7 (24) <0.0005
More morning type
than evening type
2.7% 4.3% 7.6% 8.8% 9.0% 18.1% 39.5%
Neither morning nor
evening type
20.5% 3.4% 4.9% 11.5% 9.5% 10.5% 39.7%
More evening type
than morning type
32.3% 2.8% 3.6% 13.7% 10.6% 6.3% 30.6%
Definitely an evening
type
46.8% 2.0% 2.0% 15.6% 8.6% 2.7% 22.3%
SOL-insomnia = Sleep onset latency insomnia, WASO-insomnia = Wake after sleep onset insomnia, EMA-insomnia = Early morning awakening insomnia. Percentages
adding up to 100% in each row. aDegrees of freedom, bPearson Chi-square.
adjusted analyses. SOL + WASO-insomnia, SOL + EMA-
insomnia and SOL + WASO + EMA-insomnia were all
stronger predictors of use of hypnotics relative to SOL-
insomnia, with SOL + WASO + EMA-insomnia remaining
the strongest predictor in both crude (OR = 2.86) and the
two adjusted (fully adjusted OR = 1.80) analyses. Compared
to SOL-insomnia, all insomnia subtypes, except SOL + EMA-
insomnia, were positively associated with alcohol consumption
three or more days per week in the crude analysis. However,
in the fully adjusted model, only WASO + EMA-insomnia and
SOL +WASO + EMA-insomnia remained positively associated
with high alcohol consumption.
DISCUSSION
In total more than 60% of the participants with chronic insomnia
disorder had either SOL-insomnia or SOL + WASO + EMA-
insomnia. These two insomnia subtypes differed considerably
regarding age. SOL-insomnia was clearly the most common
insomnia subtype among younger participants. On the
contrary, more than half of the oldest participants reported
SOL + WASO + EMA-insomnia. The distribution of insomnia
subtypes within the other demographic characteristics showed
that participants with female sex, low level of education and
who were divorced, separated or a widow/widower had a higher
prevalence of SOL + WASO + EMA-insomnia compared to
participants with male sex, high level of education and who
were married, cohabitant or single, respectively. Almost all
epidemiological studies have reported an increased prevalence
of insomnia symptoms with female sex, age and when being
separated, divorced or a widow/widower and having a low level of
education (Ohayon, 2002). Our findings further contribute to the
research area by adding knowledge about the distribution of these
characteristics within different insomnia subtypes, particularly
their strong association with SOL+WASO+ EMA-insomnia.
Moreover, our findings indicated that possible anxiety and
possible depression more frequently occurred in participants
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TABLE 3 | The percentage distribution of alcohol consumption, hypnotic use, and mental health within each specific insomnia subtype (n = 64 503).
SOL- WASO- EMA- SOL +WASO- SOL + EMA- WASO + EMA- SOL +WASO + Chi-square p-valued
insomnia insomnia insomnia insomnia -insomnia -insomnia EMA-insomnia (df)c
Alcohol consumption
No 29.7% 32.7% 33.9% 33.1% 34.9% 31.4% 35.9% 901.7 (24) <0.0005
Rarely 35.3% 30.4% 30.5% 31.3% 33.4% 25.1% 27.1%
1–2 times per week 29.6% 26.7% 26.9% 28.5% 26.1% 30.7% 27.6%
3–5 times per week 4.9% 8.6% 7.2% 6.4% 4.8% 10.2% 7.6%
Daily 0.6% 1.7% 1.4% 0.8% 0.8% 2.6% 1.7%
Use of hypnotics
Yes 11.4% 7.6% 8.6% 16.2% 16.6% 12.5% 26.8% 2046.0 (6) <0.0005




61.6% 50.8% 55.8% 65.3% 68.1% 54.5% 67.7% 656.8 (6) <0.0005
Possible depression
(HAD-D ≥ 8)b
34.0% 32.5% 34.1% 40.4% 41.1% 33.3% 46.0% 756.8 (6) <0.0005
SOL-insomnia = Sleep onset latency insomnia, WASO-insomnia = Wake after sleep onset insomnia, EMA-insomnia = Early morning awakening insomnia. Percentages
adding up to 100% in each column. aHAD-A = Hospital Anxiety and Depression Scale—Anxiety subscale, bHAD-D = Hospital Anxiety and Depression Scale—Depression
subscale, cDegrees of freedom, dPearson Chi-square.
TABLE 4 | Logistic regression analyses with possible anxiety, possible depression, hypnotic use, and alcohol consumption as dependent variables, and the specific
insomnia subtypes as predictors in a Norwegian web-based study (n = 64 503).
Possible anxiety (HAD-Aa ≥ 8) Possible depression (HAD-Db ≥ 8)
Crude OR Adjusted ORc Adjusted ORd Crude OR Adjusted ORc Adjusted ORd
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
SOL-insomnia 1.00 1.00 1.00 1.00 1.00 1.00
WASO-insomnia 0.64 (0.58–0.71) 0.84 (0.76–0.93) 0.85 (0.77–0.93) 0.94 (0.85–1.04) 1.08 (0.97–1.20) 1.11 (1.00–1.23)
EMA-insomnia 0.79 (0.73–0.85) 1.06 (0.97–1.15) 1.06 (0.98–1.16) 1.00 (0.92–1.09) 1.13 (1.04–1.23) 1.15 (1.06–1.26)
SOL + WASO-insomnia 1.17 (1.11–1.24) 1.33 (1.26–1.41) 1.32 (1.25–1.40) 1.32 (1.24–1.39) 1.41 (1.33–1.49) 1.40 (1.32–1.48)
SOL + EMA-insomnia 1.33 (1.25–1.42) 1.47 (1.38–1.57) 1.45 (1.36–1.55) 1.35 (1.27–1.44) 1.43 (1.35–1.52) 1.40 (1.31–1.49)
WASO + EMA-insomnia 0.75 (0.70–0.79) 1.15 (1.08–1.23) 1.17 (1.10–1.25) 0.97 (0.91–1.03) 1.18 (1.11–1.26) 1.23 (1.15–1.31)
SOL + WASO + EMA-insomnia 1.31 (1.25–1.36) 1.79 (1.71–1.88) 1.76 (1.68–1.84) 1.66 (1.59–1.73) 1.93 (1.84–2.02) 1.87 (1.79–1.96)
Use of hypnotics (yes) Alcohol consumption (>3 days per week)
Crude OR Adjusted ORc Adjusted ORd Crude OR Adjusted ORc Adjusted ORd
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
SOL-insomnia 1.00 1.00 1.00 1.00 1.00 1.00
WASO-insomnia 0.64 (0.54–0.77) 0.40 (0.33–0.48) 0.40 (0.34–0.48) 1.97 (1.67–2.32) 1.23 (1.03–1.45) 1.14 (0.97–1.36)
EMA-insomnia 0.73 (0.64–0.84) 0.47 (0.41–0.55) 0.48 (0.42–0.55) 1.63 (1.41–1.88) 0.98 (0.84–1.14) 0.94 (0.81–1.09)
SOL + WASO-insomnia 1.51 (1.40–1.63) 1.20 (1.11–1.30) 1.20 (1.11–1.30) 1.34 (1.20–1.49) 1.06 (0.95–1.19) 1.06 (0.95–1.19)
SOL + EMA-insomnia 1.55 (1.42–1.68) 1.31 (1.20–1.42) 1.29 (1.19–1.41) 1.02 (0.90–1.17) 0.85 (0.75–0.97) 0.88 (0.77–1.01)
WASO + EMA-insomnia 1.11 (1.02–1.22) 0.59 (0.54–0.65) 0.60 (0.55–0.66) 2.53 (2.29–2.79) 1.26 (1.13–1.40) 1.18 (1.06–1.32)
SOL + WASO + EMA-insomnia 2.86 (2.70–3.02) 1.81 (1.70–1.92) 1.80 (1.69–1.91) 1.78 (1.64–1.93) 1.05 (0.96–1.14) 1.10 (1.00–1.20)
SOL-insomnia = Sleep onset latency insomnia, WASO-insomnia = Wake after sleep onset insomnia, EMA-insomnia = Early morning awakening insomnia, 95% CI = 95%
confidence interval. aHAD-A = Hospital Anxiety and Depression Scale—Anxiety subscale, bHAD-D = Hospital Anxiety and Depression Scale—Depression subscale,
cAdjusted for sex and age, dAdjusted for sex, age, level of education and marital status.
with SOL + WASO + EMA-insomnia compared with SOL-
insomnia. While this is somewhat in contrast with previous
studies suggesting depression to be more strongly associated
with early morning awakening (Rodin et al., 1988; Lustberg and
Reynolds, 2000) or difficulty initiating sleep (Yokoyama et al.,
2010; Ikeda et al., 2017), it is important to emphasize that
previous studies did not include mixed insomnia subtypes. It can
therefore not be ruled out that these studies would have provided
similar results as the current study if they had also included
combinations of the insomnia subtypes. Based on our results
we argue that SOL + WASO + EMA-insomnia has a greater
impact on daily life compared to the other subtypes, considering
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the especially close relationship between possible anxiety and
possible depression and SOL + WASO + EMA-insomnia. This
assumption seems conceivable as this insomnia subtype should
be regarded as the most serious as it implies sleeplessness in
all temporal phases of the main sleep episode. Espie et al.
(2012) support this finding by suggesting that participants with
a combination of insomnia symptoms have greater impairment
in several important areas of daily functioning, particularly
energy and mood. Taylor et al. (2005) suggested that people
with combined insomnia had the highest depression score,
while they found no differences on anxiety scores between
insomnia subtypes, thereby partly supporting the findings of the
current study. It is worth mentioning that possible anxiety was
least frequent in participants experiencing WASO-insomnia. We
assume that this finding could be explained by the nature of
anxiety as worrying while still awake in the evening and after
waking up in the morning, where both would disturb the ability
to sleep (Clancy et al., 2020).
Our assumption about alcohol was inconsistent with our
findings. WASO + EMA-insomnia was associated with the
most frequent alcohol consumption. This may be explained by
alcohol’s effect on sleep patterns, where alcohol at bedtime may
facilitate sleep onset, but typically causes sleep disruption in
the second half of the sleep period (Ohayon, 2002; Ebrahim
et al., 2013). However, alcohol loses its effect on sleep onset,
while sleep disruption remains when consumed frequently
(Ohayon, 2002). This may explain why SOL +WASO + EMA-
insomnia also was associated with a high alcohol consumption
in the fully adjusted logistic regression. Drinking quantity and
frequency are previously reported to be independent predictors
of insomnia (Kim et al., 2017). It is also found that patients
with alcohol abuse problems have significantly higher insomnia
scores than those without (Atalay, 2011). Still, alcohol is often
used as a self-treatment strategy in the general population
(Ohayon, 2002). Indeed, some longitudinal studies have attested
to the assumption that insomnia may be a risk factor for
future problematic alcohol consumption (Hasler et al., 2014).
Conversely, longitudinal studies have also shown that quantity
of drinking may predict future insomnia severity (Zhabenko
et al., 2013). Based on the current literature it seems reasonable
to assume a bi-directional relationship between insomnia and
alcohol consumption. Regarding insomnia subtypes, Edinger
et al. (1996) found that patients suffering from insomnia
associated with alcohol use complained of both sleep onset
insomnia and sleep maintenance insomnia (including wake after
sleep onset and early morning awakening), and that these patients
had the longest histories of insomnia complaints compared
to other patients. However, that finding is based on a cluster
consisting of 5 patients only (Edinger et al., 1996).
As for use of hypnotics, our assumption was consistent with
our findings. SOL + WASO + EMA-insomnia was clearly
associated with the highest use of hypnotics, which may be
another representation of the greater impact on daily life
experienced by participants with this insomnia subtype or
reflecting the fact that this subtype is the most burdensome in
terms of the nocturnal symptoms. The subtypes that did not
include sleep onset problems were less associated with use of
hypnotics than SOL-insomnia in the adjusted logistic analyses.
Our findings therefore suggest that prolonged sleep onset may
be a potent antecedent for use of hypnotics. The efficacy of
pharmacological therapy for chronic sleep onset insomnia was
evaluated in a randomized, placebo-controlled clinical trial and
the finding suggests that patients with sleep onset insomnia
can derive significantly greater benefit from cognitive behavioral
therapy (CBT-I) than pharmacotherapy (Jacobs et al., 2004). This
is consistent with the most recent guidelines considering CBT-I as
the first-line treatment for chronic insomnia disorder (Riemann
et al., 2017). Despite this, CBT-I is not well known by health
care practitioners and remains underused in clinical practice.
Insomnia is thereby undertreated, and hypnotics are prescribed
too often for long-term use, possibly leading to tolerance and a
rebound effect at discontinuation (Ohayon, 2002).
The present study has several limitations that should be noted.
The prevalence of SOL-insomnia gradually decreased with age in
the present study. The reported circadian preference seemed to be
a contributing factor to these findings. This emphasizes a possible
limitation of the present study, where other sleep disorders such
as a circadian rhythm sleep-wake disorder may be difficult to
differentiate from an insomnia disorder. In this regard it should
be noted that being an evening type was clearly associated with
SOL-insomnia. Younger participants not being able to fall asleep
in the evening could in some cases therefore be suffering from
a circadian rhythm sleep-wake disorder (delayed sleep-wake
phase disorder), rather than insomnia disorder (Hysing et al.,
2013; Alvaro et al., 2014; Gupta et al., 2014; Benjamins et al.,
2017; Riemann et al., 2017; Blake et al., 2018). A potential new
study should address this issue by including more questions
related to circadian rhythm sleep-wake disorders. Questions
regarding drug abuse, other pharmacological treatments and
symptoms of disorders beyond anxiety and depression were
not included in the current study. Thus, future studies should
investigate a wider array of potential covariates in terms of their
associations with insomnia subtypes. While the high prevalence
of SOL-insomnia found in younger participants could mirror
a high rate of true insomnia, it could thus also reflect the
need for adjustment of some of the criteria for SOL-insomnia.
Nevertheless, the cut-off for SOL-insomnia of 30 min or more is
based on epidemiological studies of adults (Hysing et al., 2013). In
addition, by adjusting for relevant factors such as sex and age we
still found significant associations between the different insomnia
subtypes and possible anxiety, possible depression and use of
alcohol and hypnotics. This information is useful for clinicians
in terms of understanding insomnia comorbidity and may thus
also have treatment implications.
Another limitation to consider concerns the duration criteria
used in BIS (one month), which is based on the criteria found
in the DSM-IV. In DSM-5, the diagnosis of chronic insomnia
disorder requires symptoms to last for at least 3 months.
However, among the participants in our study 87.1% reported a
duration of insomnia symptoms for six months or longer. We
therefore argue that the used duration criteria most likely had
minor impacts on the results. In addition, both the BIS and the
HADS are considered standardized and validated instruments.
BIS is regarded as a well validated questionnaire with good
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psychometric properties (Pallesen et al., 2008; Riemann et al.,
2017), and HADS is found to have sensitivities and specificities
of approximately 0.80 for both subscales using the cut-off used
in the present study (Bjelland et al., 2002). It is also worth
mentioning that HADS does not include sleep disturbance items,
thereby precluding tautology when assessing the relationship
with sleep variables (Neckelmann et al., 2007). Still, it should be
noted that neither the BIS nor HADS provide a clinical diagnosis
of insomnia, anxiety or depression, respectively.
Another limitation to consider is the concern first raised
by Hohagen et al. (1994) who reported variability in insomnia
subtypes over time. In their study, no more than about half of
the patients remained classified with the same insomnia subtype
at baseline and at the 4-month follow-up. Regardless of temporal
stability, treatment based on insomnia subtype can be initiated at
the time of diagnosis and then be changed if the insomnia subtype
changes. Change in insomnia subtype over time may as well
reflect treatment-response. Future studies should nevertheless
include at least one follow-up in order to assess the temporal
stability of insomnia subtypes.
The common methodological disadvantages of a self-
report questionnaire-based study such as recall bias, common
method bias and social desirability bias should further be
considered as limitations (Podsakoff et al., 2003). In future
studies these limitations may be overcome by using clinical
interviews instead of questionnaires. A final limitation to
consider is the possibility of selection bias. However, the
possible selection bias is considered less significant when
adjusting for relevant factors. In addition, we argue that
several of the aforementioned limitations are mitigated by
the large sample size achieved in the present study. As
mentioned, all insomnia subtypes had a sample size of more
than 1900 participants. To the best of our knowledge, the
present study is the largest to date, which we consider its most
important asset.
The present study could help clinical practitioners to tailor
treatment approach based on characteristics and comorbidity of
insomnia subtypes. To be able to do this, we argue that there
is a need for a simple and clinically applicable classification of
subtypes of insomnia. To be clinically applicable, we divided
into insomnia subtypes based on their temporal association with
the main sleep period. Our results suggested that insomnia is
a heterogenic disorder and that there are differences between
the insomnia subtypes’ effect on daily life. Participants with
SOL + WASO + EMA-insomnia seemed to be suffering from
a higher burden than participants with the other insomnia
subtypes. They were more likely to have possible anxiety
and depression, high alcohol consumption and hypnotic use
compared to those suffering from other insomnia subtypes.
Further research is required to determine whether tailored
treatment in line with the insomnia subtypes will have clinical
consequences in terms of treatment response.
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